Japanese Encephalitis Vaccine | Japanese Encephalitis Virus | CDC
May 15, 2024 · One Japanese encephalitis vaccine (called IXIARO) is available in the United States. Japanese encephalitis vaccine is approved for use in children aged 2 months and …
IXIARO is a vaccine indicated for the prevention of disease caused by Japanese encephalitis virus (JEV). IXIARO is approved for use in individuals 2 months of age and older.
Ixiaro Vaccine: Schedule, Side Effects & Warnings - Drugs.com
Jan 3, 2025 · What is Ixiaro vaccine? Ixiaro vaccine is used to help prevent Japanese encephalitis in adults and adolescents who are at least 17 years old. Japanese encephalitis is a serious …
Japanese Encephalitis Vaccine – IXIARO® - Valneva
Jul 11, 2019 · IXIARO®, or JESPECT® in Australia and New Zealand, is an inactivated Japanese encephalitis vaccine and is the only Japanese encephalitis vaccine currently approved for use …
Ixiaro: Package Insert / Prescribing Info - Drugs.com
Dec 2, 2024 · IXIARO is a vaccine indicated for active immunization for the prevention of disease caused by Japanese encephalitis virus (JEV). IXIARO is approved for use in individuals 2 …
Japanese Encephalitis Vaccine Information for Healthcare ...
One inactivated Japanese encephalitis (JE) vaccine (manufactured as IXIARO) is available in the United States. JE vaccine is approved for use in children aged 2 months and older and adults. …
Home - IXIARO HCP
Help protect them from Japanese encephalitis (JE) with IXIARO.1. What is JE? JE is a potentially fatal mosquito-borne disease, for which no treatment is available.2–5.
- Some results have been removed